Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Post by palinc2000on Dec 01, 2021 2:02pm
264 Views
Post# 34186149

analogy

analogyThe hard part for the market is to try to figure out how the different undertakings will be funded and what will be the breakdown between       1- funds  generated from the commercial operations-2-out licensing/partership -3-stock offering -4 debt .  Moreover we dont know HOW much funds will be needed and the timeline .....That is a lot to swallow !!!!

It reminds me of a construction site where you see a large  picture of a multi storey building and all you see is a big hole and you can hear  the sound of heavy equipment  and a lot of people running around (white helmets and green helmets.......THe difference with THRX is that there is a completion date shown and presumably the project is completely funded....


So Paul is building a base for a high rise building  .....how many floors? what cost?  which funds?
Presumably Paul has  approximate answers..to these  questions ,,,otherwise the construction site would be vacant.....
<< Previous
Bullboard Posts
Next >>